about
Solving protein structures using short-distance cross-linking constraints as a guide for discrete molecular dynamics simulations.Current trends in quantitative proteomics - an update.Verification of a Proteomic Biomarker Panel to Diagnose Minor Stroke and Transient Ischaemic Attack: Phase 1 of SpecTRA, a Large Scale Translational Study.ExSTA: External Standard Addition Method for Accurate High-Throughput Quantitation in Targeted Proteomics Experiments.Immuno-Matrix-Assisted Laser Desorption/Ionization Assays for Quantifying AKT1 and AKT2 in Breast and Colorectal Cancer Cell Lines and Tumors.Multiplexed MRM-Based Protein Quantitation Using Two Different Stable Isotope-Labeled Peptide Isotopologues for Calibration.Bead-Extractor Assisted Ready-to-Use Reagent System (BEARS) for Immunoprecipitation Coupled to MALDI-MS.Top-Down Hydrogen-Deuterium Exchange Analysis of Protein Structures Using Ultraviolet Photodissociation.Proteomic Profiling of Leishmania donovani Promastigote Subcellular Organelles.Molecular phenotyping of laboratory mouse strains using 500 multiple reaction monitoring mass spectrometry plasma assaysDetecting post-translational modification signatures as potential biomarkers in clinical mass spectrometryValidation of a proteomic biomarker panel to diagnose minor-stroke and transient ischaemic attack: phase 2 of SpecTRA, a large scale translational study.Conformational ensemble of native α-synuclein in solution as determined by short-distance crosslinking constraint-guided discrete molecular dynamics simulationsThe Special Issue: Clinical Proteomics for Precision MedicineGenetic Variation in 9p21 and the Plasma ProteomeMaternal Apolipoprotein B100 Serum Levels are Diminished in Pregnancies with Intrauterine Growth Restriction and Differentiate from ControlsImproving Identification of In-organello Protein-Protein Interactions Using an Affinity-enrichable, Isotopically Coded, and Mass Spectrometry-cleavable Chemical CrosslinkerMultiplexed targeted proteomic assay to assess coagulation factor concentrations and thrombosis-associated cancerA Unique Morphological Phenotype in Chemoresistant Triple-Negative Breast Cancer Reveals Metabolic Reprogramming and PLIN4 Expression as a Molecular VulnerabilityMultiplexed LC-ESI-MRM-MS-based Assay for Identification of Coronary Artery Disease Biomarkers in Human PlasmaImmuno-MALDI (iMALDI) mass spectrometry for the analysis of proteins in signaling pathwaysTargeted and Untargeted Proteomics Approaches in Biomarker DevelopmentDetermination of the concentration range for 267 proteins from 21 lots of commercial human plasma using highly multiplexed multiple reaction monitoring mass spectrometryFirst Community-Wide, Comparative Cross-Linking Mass Spectrometry StudyConcentration Determination of >200 Proteins in Dried Blood Spots for Biomarker Discovery and ValidationIncreased sulfation of bile acids in mice and human subjects with sodium taurocholate cotransporting polypeptide deficiency
P50
Q38684964-133A3039-87FC-4460-A905-6CD83E0298FBQ38832695-6200F11C-6C33-4379-8B83-9EB28F4110F6Q47554120-832487EE-5A5C-4C4D-BE0B-88C24AF2C9C5Q47818859-1A67DE6B-3DA9-44CA-A70A-6C82900D4E52Q47884714-E1464D80-31DD-467E-92AA-4F5E152EBCB5Q48128181-C86E05B3-76F0-40D9-888A-6D4655580C09Q48166538-91E44184-8D51-4826-8494-76D2AEAC723CQ48237420-0CB555FE-E486-482D-9C99-F92EAE681616Q48247719-D634769E-05F3-4CC3-B2F9-FF2C6EA57E0AQ57143261-94B44A6C-FBA4-4DF4-BE4D-27B2A98EACC0Q57842083-8DD3346F-8F80-4A85-80FF-46011BFDB485Q63916003-6E2C2F62-E58D-446F-9F16-081C24E1D248Q64114775-88F5B272-4300-4E02-9925-AB615E21C189Q88009397-373BEADD-008C-458A-9B08-823E75ACEF18Q89111544-030BDA27-0965-4A33-A7EF-53B797111C42Q89340607-BBEC9DE8-C176-4AB7-BB1B-6E6C06483C5EQ89685502-70C6E990-58EC-4521-84D3-A7A3963F44C7Q89777016-C30E1F25-0D3A-4ED0-BFA2-194B846329DAQ90182242-9A896388-3A7A-438C-A3BD-CA9863073FF9Q90996989-E8FCA16A-5C99-4D5E-8B62-20A44A960054Q91248577-79CC0E66-E6CB-4900-9CE3-93DD33D3BB6AQ91290834-9EC789E3-EE41-4035-A334-33AA91A0F1E8Q91627774-16FE1999-E5A4-495A-B1A9-E47E0FC768C6Q91689619-A1230002-48D2-44A6-A73E-B95ABFC5A1A9Q92380091-B1CD49D9-E8F2-464A-8063-D5D735F0C07FQ92760837-49D11721-23D7-457D-B1EB-C0CC7FE310B5
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Christoph H Borchers
@en
Christoph H Borchers
@nl
type
label
Christoph H Borchers
@en
Christoph H Borchers
@nl
prefLabel
Christoph H Borchers
@en
Christoph H Borchers
@nl
P31
P496
0000-0003-2394-6512